The association between maternal hepatitis B e antigen status, as a proxy for perinatal transmission, and the risk of hepatitis B e antigenaemia in Gambian children

BMC Public Health

Volumn 14, Issue 1, 2014, Pages

  Shimakawa, Yusuke ^a,b   Bottomley, Christian ^b   Njie, Ramou ^a,c   Mendy, Maimuna ^d  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c Gambia Hepatitis Intervention Study IARC C/o MRC Unit ^*  (Gambia)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Africa; Age factors; Hepatitis B; Hepatitis B e antigens; Infectious disease transmission; Vertical

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN;

ADOLESCENT; ADULT; AGE; BLOOD; CHILD; FEMALE; GAMBIA; HEALTH SURVEY; HEPATITIS B, CHRONIC; HUMAN; INFANT; MALE; MIDDLE AGED; MOTHER; NEWBORN; PREGNANCY; PRESCHOOL CHILD; PREVALENCE; TRANSMISSION; VERTICAL TRANSMISSION; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; FEMALE; GAMBIA; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; MIDDLE AGED; MOTHERS; POPULATION SURVEILLANCE; PREGNANCY; PREVALENCE; YOUNG ADULT;

EID: 84903518979     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-14-532     Document Type: Article

References (40)

1. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 100. A Review of Human Carcinogens. Part B. Biological Agents Lyon, France: International Agency for Research on Cancer 2011 1 487
2. The influence of age on the development of the hepatitis B carrier state. Edmunds WJ, Medley GF, Nokes DJ, Hall AJ, Whittle HC, Proc Biol Sci 1993 253 197 201 10.1098/rspb.1993.0102 8397416
3. Host responses to hepatitis-B infection in patients with primary hepatic carcinoma and their families. A case/control study in Senegal, West Africa. Larouze B, Saimot G, Lustbader ED, London WT, Werner BG, Payet M, Lancet 1976 2 534 538 60621
4. Long-term effect of maternal HBeAg on delayed HBeAg seroconversion in offspring with chronic hepatitis B infection. Tseng YR, Wu JF, Ni YH, Chen HL, Chen CC, Wen WH, Hsu HY, Chang MH, Liver Int 2011 31 1373 1380 10.1111/j.1478-3231.2011.02574.x 21745315
5. Natural history of chronic hepatitis B in Euro-Mediterranean and African countries. Hadziyannis SJ, J Hepatol 2011 55 183 191 10.1016/j.jhep.2010.12.030 21238520
6. Association of early age at establishment of chronic hepatitis B infection with persistent viral replication, liver cirrhosis and hepatocellular carcinoma: a systematic review. Shimakawa Y, Yan H-J, Tsuchiya N, Bottomley C, Hall AJ, PLoS One 2013 8 69430 10.1371/journal.pone.0069430 23894479
7. Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas. Edmunds WJ, Medley GF, Nokes DJ, O'Callaghan CJ, Whittle HC, Hall AJ, Epidemiol Infect 1996 117 313 325 10.1017/S0950268800001497 8870629
8. Hepatitis B virus infection in two Gambian villages. Whittle HC, Bradley AK, McLauchlan K, Lancet 1983 1 1203 1206 6133999
9. The Pattern of Childhood Hepatitis B Infection in Two Gambian Villages. Whittle H, Inskip H, Bradley AK, McLaughlan K, Shenton F, Lamb W, Eccles J, Baker BA, Hall AJ, J Infect Dis 1990 161 1112 1115 10.1093/infdis/161.6.1112 2345294
10. The Gambia hepatitis intervention study. The Gambia Hepatitis Study Group, Cancer Res 1987 47 5782 5787 2822233
11. Risk factors for transmission of hepatitis B virus to Gambian children. Vall Mayans M, Hall A, Inskip H, Chotard J, Lindsay S, Alonso P, Coromina E, Mendy M, Whittle H, Lancet 1990 336 1107 1109 10.1016/0140-6736(90)92580-B 1977989
12. Causal diagrams for epidemiologic research. Greenland S, Pearl J, Robins JM, Epidemiol 1999 10 37 48 10.1097/00001648-199901000-00008
13. Vaccination against hepatitis B and protection against chronic viral carriage in The Gambia. Whittle HC, Inskip H, Hall AJ, Mendy M, Downes R, Hoare S, Lancet 1991 337 747 750 10.1016/0140-6736(91)91367-4 1672389
14. Cross-sectional and longitudinal epidemiology of hepatitis B in Senegal. Barin F, Perrin J, Chotard J, Denis F, N'Doye R, Diop Mar I, Chiron JP, Coursaget P, Goudeau A, Maupas P, Prog Med Virol 1981 27 148 162 6972051
15. Hepatitis B virus carrier state in Black children in Ovamboland: Role of perinatal and horizontal infection. Botha JF, Dusheiko GM, Ritchie MJJ, Mouton HWK, Kew MC, Lancet 1984 323 1210 1212 10.1016/S0140-6736(84)91694-5
16. Changes in viral load and HBsAg and HBeAg status with age in HBV chronic carriers in The Gambia. Mendy ME, McConkey SJ, van der Sande MAB, Crozier S, Kaye S, Jeffries D, Hall AJ, Whittle HC, Virol J 2008 5 49 10.1186/1743-422X-5- 49 18416832
17. Hepatitis B virus as the etiologic agent in hepatocellular carcinoma-epidemiologic considerations. Beasley RP, Hepatology 1982 2 suppl 21S 26S
18. Natural seroconversion of HBe antigen to anti-HBe in HBs antigen carrier children-From the difference of the modes of HBV transmission [Japanese]. Kojima M, Yasuda M, Tanaka H, Adachi N, MS, Acta Hepatol Jpn 1985 26 1139 1145 10.2957/kanzo.26.1139
19. Factors affecting clearance of hepatitis B e antigen in hepatitis B surface antigen carrier children. Chang MH, Sung JL, Lee CY, Chen CJ, Chen JS, Hsu HY, Lee PI, Chen DS, J Pediatr 1989 115 385 390 10.1016/S0022-3476(89)80836- 4 2769497
20. Chronic hepatitis B in male and female children of HBsAg carrier mothers. Wheeley SM, Tarlow MJ, Boxall EH, J Hepatol 1989 8 226 231 10.1016/0168- 8278(89)90011-1 2715622
21. Liver function and hepatitis markers in carriers of hepatitis B virus in New Zealand. Hopkirk N, Moyes CD, Lucas CR, N Z Med J 2000 113 114 116 10834277
22. Histologic activity of childhood chronic hepatitis B related to viremia levels, genotypes, mutations, and epidemiologic factors. Soderstrom A, Norkrans G, Conradi N, Krantz M, Horal P, Lindh M, J Pediatr Gastroenterol Nutr 2002 35 487 494 10.1097/00005176-200210000-00006 12394372
23. Persistent hepatitis B virus infection and hepatoma in The Gambia, west Africa. A case-control study of 140 adults and their 603 family contacts. Ryder RW, Whittle HC, Sanneh AB, Ajdukiewicz AB, Tulloch S, Yvonnet B, Am J Epidemiol 1992 136 1122 1131 1334367
24. Age at first establishment of chronic hepatitis B virus infection and hepatocellular carcinoma risk: A birth order study. Hsieh CC, Tzonou A, Zavitsanos X, Kaklamani E, Lan SJ, Trichopoulos D, Am J Epidemiol 1992 136 1115 1121 1334366
25. Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. Chu C, Hussain M, Lok ASF, Gastroenterology 2002 122 1756 1762 10.1053/gast.2002.33588 12055581
26. Prevalence of HBV core promoter/precore/core mutations in Gambian chronic carriers. Dumpis U, Mendy M, Hill A, Thursz M, Hall A, Whittle H, Karayiannis P, J Med Virol 2001 65 664 670 10.1002/jmv.2088 11745929
27. Seasonal variation in TP53 R249S-mutated serum DNA with aflatoxin exposure and hepatitis B virus infection. Villar S, Le Roux-Goglin E, Gouas DA, Plymoth A, Ferro G, Boniol M, Lereau M, Bah E, Hall AJ, Wild CP, Mendy M, Norder H, van der Sande M, Whittle H, Friesen MD, Groopman JD, Hainaut P, Environ Health Perspect 2011 119 1635 1640 10.1289/ehp.1103539 21768053
28. TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The Gambia. Gouas DA, Villar S, Ortiz-Cuaran S, Legros P, Ferro G, Kirk GD, Lesi OA, Mendy M, Bah E, Friesen MD, Groopman J, Chemin I, Hainaut P, Carcinogenesis 2012 33 1219 1224 10.1093/carcin/bgs135 22759751
29. Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes. Kramvis A, Kew MC, Hepatol Res 2007 37 9 S19 10.1111/j.1872-034X.2007.00098.x 17627641
30. Phylogenetic analysis of the precore/core gene of hepatitis B virus genotypes E and A in West Africa: new subtypes, mixed infections and recombinations. Olinger CM, Venard V, Njayou M, Oyefolu AOB, Maïga I, Kemp AJ, Omilabu SA, le Faou A, Muller CP, J Gen Virol 2006 87 1163 1173 10.1099/vir.0.81614-0 16603517
31. Observational study of vaccine efficacy 24 years after the start of hepatitis B vaccination in two Gambian villages: no need for a booster dose. Mendy M, Peterson I, Hossin S, Peto T, Jobarteh ML, Jeng-Barry A, Sidibeh M, Jatta A, Moore SE, Hall AJ, Whittle H, PLoS One 2013 8 58029 10.1371/journal.pone.0058029 23533578
32. Minimization of hepatitis B infection by a 25-year universal vaccination program. Ni Y-H, Chang M-H, Wu J-F, Hsu H-Y, Chen H-L, Chen D-S, J Hepatol 2012 57 730 735 10.1016/j.jhep.2012.05.021 22668640
33. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. Chen H-L, Lin L-H, Hu F-C, Lee J-T, Lin W-T, Yang Y-J, Huang F-C, Wu S-F, Chen SC-C, Wen W-H, Chu C-H, Ni Y-H, Hsu H-Y, Tsai P-L, Chiang C-L, Shyu M-K, Lee P-I, Chang F-Y, Chang M-H, Gastroenterology 2012 142 773 781 e2 10.1053/j.gastro.2011.12.035 22198276
34. Hepatitis B vaccination: The key towards elimination and eradication of hepatitis B. Chen D-S, J Hepatol 2009 50 805 816 10.1016/j.jhep.2009.01.002 19231008
35. Evaluation of policies and practices to prevent mother to child transmission of hepatitis B virus in China: Results from China GAVI project final evaluation. Cui F, Luo H, Wang F, Zheng H, Gong X, Chen Y, Wu Z, Miao N, Kane M, Hennessey K, Hadler SC, Hutin YJ, Liang X, Yang W, Vaccine 2013 31 Suppl 9 36 J42 24331019
36. Implementing a birth dose of hepatitis B vaccine for home deliveries in Africa-Too soon? Kramvis A, Clements CJ, Vaccine 2010 28 6408 6410 10.1016/j.vaccine.2010.07.042 20673825
37. Global routine vaccination coverage, 2012. WHO, Wkly Epidemiol Rec 2013 88 482 486 24236333
38. Hepatitis B vaccine in the Expanded Programme of Immunisation: the Gambian experience. The Gambia Hepatitis Study Group, Lancet 1989 1 1057 1060 2566008
39. Hepatitis B e antigen and the risk of hepatocellular carcinoma. Yang HI, Lu SN, Liaw YF, You SL, Sun CA, Wang LY, Hsiao CK, Chen PJ, Chen DS, Chen CJ, N Engl J Med 2002 347 168 174 10.1056/NEJMoa013215 12124405
40. Hepatitis B vaccines. WHO position paper. WHO, Wkly Epidemiol Rec 2009 84 405 420 19817017